NCT05579340

Brief Summary

Up to 25% of colorectal cancer (CRC) patients are diagnosed with liver metastases, which is the most common site of metastasis, already during the primary tumor diagnosis. Another 30% of the patients will develop liver metastases at a later stage. Even though patient can be treated by surgical resection of the metastatic tumor, 50-75% of the patients experience a relapse in less than two years. Due to the high probability of relapse, mCRC patients undergo multiple rounds of surgery and adjuvant treatment (chemotherapy/radiotherapy) which results in substantial physical de-conditioning. Physical activity has been shown to increase the progression-free survival rates in mCRC patients, when applied post-diagnosis. Increased cardiorespiratory fitness (VO2peak) at the time of diagnosis among CRC individuals has been associated with lower risk of all-cause mortality. Although data on the effect of chronic exercise on VO2peak have emerged, thus far, there is no randomized clinical trial that has investigated the effects of exercise training in mCRC patients early after surgical treatment with curative intent. Therefore, this project aims to address the beneficial effect of structured exercise training primarily on VO2peak and tumor recurrence in mCRC patients immediately after surgical treatment and while they are undergoing adjuvant chemotherapy/radiotherapy. A total of 66 participants will be recruited from the Department of Surgery and Transplantation, Rigshospitalet and randomly allocated to a standard care control group (n=22), standard care plus 150 min/week exercise training (n=22) or standard care plus 300 min/week exercise training (n=22). Participants will undergo exercise training for 6 months, starting immediately after surgery, and they will be followed for additional 6 months. Tumor recurrence will be evaluated up to 3 years after training initiation.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
66

participants targeted

Target at P50-P75 for not_applicable

Timeline
24mo left

Started Apr 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress60%
Apr 2023Jun 2028

First Submitted

Initial submission to the registry

September 22, 2022

Completed
21 days until next milestone

First Posted

Study publicly available on registry

October 13, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

April 18, 2023

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2028

Last Updated

February 24, 2026

Status Verified

February 1, 2026

Enrollment Period

3.1 years

First QC Date

September 22, 2022

Last Update Submit

February 20, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in peak oxygen consumption (VO2peak)

    Changes in VO2peak assessed during an incremental exercise test to volitional exhaustion on a bicycle ergometer

    Baseline, 3-, 6-, 9- and 12 months after exercise training initiation

Secondary Outcomes (62)

  • 3-years recurrence-free survival

    Randomization to 3 years after randomization

  • 3-years overall survival

    Randomization to 3 years after randomization

  • Changes in Aerobic Capacity: Ventilatory threshold

    Baseline, 3-, 6-, 9- and 12 months after exercise training initiation

  • Changes in Aerobic Capacity: Peak power output

    Baseline, 3-, 6-, 9- and 12 months after exercise training initiation

  • Changes in Muscle strength: Hand grip strength

    Baseline, 3-, 6-, 9- and 12 months after exercise training initiation

  • +57 more secondary outcomes

Study Arms (3)

Usual care

NO INTERVENTION

Ex1

EXPERIMENTAL

Low exercise volume (150 min/week)

Other: Exercise

Ex2

EXPERIMENTAL

High exercise volume (300 min/week)

Other: Exercise

Interventions

6 months of combined aerobic and resistance exercise

Ex1Ex2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Colorectal cancer patients diagnosed with liver metastasis and scheduled for liver metastasis surgical resection

You may not qualify if:

  • Age \<18
  • Pregnancy
  • Physical or mental disabilities that prohibit execution of test or training procedures
  • Inability to understand the Danish language.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rigshospitalet (CFAS)

Copenhagen, 2100, Denmark

Location

MeSH Terms

Conditions

Colonic Neoplasms

Interventions

Exercise

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Casper Simonsen, PhD

    Group Leader

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Postdoctoral researcher

Study Record Dates

First Submitted

September 22, 2022

First Posted

October 13, 2022

Study Start

April 18, 2023

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

June 1, 2028

Last Updated

February 24, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations